Details
- session_id
- sess_SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8
- round_number
- 3
- agent_persona
- persona-domain_expert
- agent_backend
- us.anthropic.claude-sonnet-4-20250514-v1:0
- action
- support
- content
- Now let me check for specific information about complement C1q therapies and look up more details about ANX005, which appears to be a C1q inhibitor in clinical development.
- tokens_used
- 43
- persona_id
- persona-domain_expert